HESI’s scientific programs provide an opportunity for academic, government, and industry scientists to interact on a peer-to-peer basis to address both emerging and long-standing challenges in safety evaluation. HESI conducts a formal citations analysis every 3-5 years, with the most recent citations analysis having been conducted in 2018. The ongoing research, discussions, critiques, and sharing of best practices within HESI are valuable contributions to the practice of science, as evidenced by the examples below.
Over 400 publications from HESI scientific programs have been published throughout the last 30 years, with more than 200 publications in peer-reviewed literature in the last decade.
HESI publications have been cited over 22,000 times in more than 3,600 different scientific journals by scientists from over 1,600 organizations (academic, government, industry, foundations, hospitals, etc.) in 75 different countries.
This figure shows the number of times HESI publications were cited each calendar year, demonstrating that citations of HESI publications have consistently increased year-over-year.
Citations for individual HESI publications (each publication is represented by a different color) by year shows a clear upward trend.
This map shows the geographic location for lead authors who have cited HESI publications, demonstrating the broad geographic reach of HESI publication citations.
The primary authors of articles citing HESI publications represent 1,653 different organizations including a wide variety of government, institute/non-profit, academic, and commercial entities.
Boulay E, Abernathy MM, Chui R, Friedrichs GS, Gendron-Parra N, Greiter-Wilke A, Guillon JM, Koerner JE, Menard A, Steidl-Nichols J, Pierson J, Pugsley MK, Rossman EI, Strauss D, Troncy E, Valentin JP, Wisialowski T, Authier S (2018) A Proof-of-Concept Evaluation of JTPc and Tp-Tec as Proarrythmia Biomarkers in Preclinical Species: A Retrospective Analysis by a HESI-Sponsored Consortium. International Journal of Pharmacology. Available online here.
Park EJ, Gintant GA, Bi D, Kozeli D, Pettit SD, Pierson JB, Skinner M, Willard J, Wisialowski T, Koerner J, Valentin JP (2017) Can Nonclinical Repolarization Assays Predict the Results of Clinical Thorough QT Studies? Results from a Research Consortium. British Journal of Pharmacology. Available online here.
Stewart J, Breslin WJ, Beyer BK, Chadwick K, De Schaepdrijver L, Desai M, Enright B, Foster W, Hui JY, Moffat GJ, Tornesi B, Van Malderen K, Wiesner L, Chen CL (2016) Birth Control in Clinical Trials: Industry Survey of Current Use Practices, Governance, and Monitoring. Therapeutic Innovation and Regulatory Science. Available online here.
Johnson GE, Soeteman-Hernández LG, Gollapudi BB, Bodger OG, Dearfield KL, Heflich RH, Hixon JG, Lovell DP, MacGregor JT, Pottenger LH, Thompson CM, Abraham L, Thybaud V, Tanir JY, Zeiger E, van Benthem J, White PA (2014) Derivation of Point of Departure (PoD) Estimates in Genetic Toxicology Studies and Their Potential Applications in Risk Assessment. Environmental and Molecular Mutagenesis. Available online here.
Gollapudi BB, Johnson GE, Hernandez LG, Pottenger LH, Dearfield KL, Jeffrey AM, Julien E, Kim JH, Lovell DP, MacGregor JT, Moore MM, van Benthem J, White PA, Zeiger E, Thybaud V (2013) Quantitative Approaches for Assessing Dose-Response Relationships in Genetic Toxicology Studies. Environmental and Molecular Mutagenesis. Available online here.